Five MIT faculty members take on Cancer Grand Challenges
Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.
Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.
During the last week of November, MIT hosted symposia and events aimed at examining the implications and possibilities of generative AI.
By analyzing bacterial data, researchers have discovered thousands of rare new CRISPR systems that have a range of functions and could enable gene editing, diagnostics, and more.
MIT researchers develop “FrameDiff,” a computational tool that uses generative AI to craft new protein structures, with the aim of accelerating drug development and improving gene therapy.
BioAutoMATED, an open-source, automated machine-learning platform, aims to help democratize artificial intelligence for research labs.
The inaugural SERC Symposium convened experts from multiple disciplines to explore the challenges and opportunities that arise with the broad applicability of computing in many aspects of society.
Matt Shoulders will lead an interdisciplinary team to improve RuBisCO — the photosynthesis enzyme thought to be the holy grail for improving agricultural yield.
The program leverages MIT’s research expertise and Takeda’s industrial know-how for research in artificial intelligence and medicine.